A Study to Assess the Mass Balance of [14C] ABBV-552 in Healthy Male Participants Following Single Oral Dose Administration

AbbVie

Status and phase: Completed; Phase 1

Conditions: Healthy Volunteer

Treatments: Drug: ABBV-552

Study type: Interventional

Funder types: Industry

Identifiers

NCT06278766

M24-416

Details and patient eligibility

About

The purpose of this study is to evaluate mass balance, pharmacokinetics and safety of [14C] ABBV-552 in healthy, male volunteers following administration of a single oral dose.

Enrollment: 8 patients

Sex: Male

Ages: 18 to 55 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Male volunteers in general good health at Screening.

Exclusion criteria

• Considering fathering a child or donating sperm during the study and for 100 days after study drug administration.

Trial design

Primary purpose: Basic Science

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

8 participants in 1 patient group

ABBV-552

Experimental group

Description:

Participants will receive ABBV-552 on Day 1.

Treatment:

Drug: ABBV-552